Company profile for HistoIndex

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are committed towards enhancing the diagnosis of chronic liver conditions like nonalcoholic steatohepatitis (NASH), and accelerating the development of effective treatments. Founded in April 2010, HistoIndex® is a MedTech spin-off company from the Institute of Biotechnology and Nanotechnology (IBN), Agency of Science, Technology and Research (A*STAR), Singapore. We are involved in the provision of optical medical imaging s...
We are committed towards enhancing the diagnosis of chronic liver conditions like nonalcoholic steatohepatitis (NASH), and accelerating the development of effective treatments. Founded in April 2010, HistoIndex® is a MedTech spin-off company from the Institute of Biotechnology and Nanotechnology (IBN), Agency of Science, Technology and Research (A*STAR), Singapore. We are involved in the provision of optical medical imaging systems and services to aid pathologists in diagnostics, clinical trials and research studies for the assessment and staging of diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Singapore
Address
Address
79 Ayer Rajah Crescent, #04-05 JTC Launchpad, Singapore, 139955
Telephone
Telephone
+65 6774 4990
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/histoindex-to-debut-fibrosight-plus-and-showcase-latest-scientific-findings-at-aasld-the-liver-meeting-2025-302584158.html

PR NEWSWIRE
14 Oct 2025

https://www.prnewswire.com/news-releases/histoindex-marks-another-step-forward-with-fibrosight-plus-introducing-ai-based-quantitative-analysis-in-fibrosis-assessment-302521784.html

PR NEWSWIRE
10 Aug 2025

https://www.globenewswire.com/news-release/2025/05/10/3078655/0/en/Akero-Therapeutics-and-HistoIndex-Present-New-Analyses-of-Phase-2b-HARMONY-Trial-in-Oral-and-Poster-Presentations-at-the-EASL-Congress-2025.html

GLOBENEWSWIRE
10 May 2025

https://www.prnewswire.com/news-releases/a-new-standard-in-clinical-care-for-mash-patients-histoindex-launches-fibrosight-302396721.html

PR NEWSWIRE
17 Mar 2025

https://www.prnewswire.com/news-releases/histoindex-charts-new-course-in-liver-disease-innovation-announces-pivotal-changes-to-scientific-advisory-board-302185815.html

PR NEWSWIRE
01 Jul 2024

https://www.prnewswire.com/news-releases/histoindex-and-galecto-to-collaborate-on-galectos-phase-2a-mylox-1-clinical-trial-to-advance-myelofibrosis-assessment-with-ai-based-stain-free-digital-pathology-301401158.html

PRNEWSWIRE
20 Oct 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty